The compelling case for anti-CD3 in type 1 diabetes

Diabetes. 2013 Nov;62(11):3656-7. doi: 10.2337/db13-1157.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • C-Peptide / metabolism*
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • C-Peptide
  • teplizumab